Prostate Cancer Reports


Volume 2 Supplement 6
 June 2014
Home > Prostate Cancer Reports > Volume 2 - Year 2014 > Supplement 6, June 2014

CONTENTS



Overall management
Guidelines
Recurrence
Treatment





Guidelines

Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D'Amico AV, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Kawachi MH, Kuettel M, Lee RJ, Macvicar GR, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Richey S, Roach M 3rd, Rohren E, Rosenfeld S, Small EJ, Srinivas S, Stein C, Strope SA, Tward J, Walsh PC, Shead DA, Ho M.
Prostate cancer, version 1.2014.
J Natl Compr Canc Netw. 2013 Dec 1;11(12):1471-9.
Abstract | Full text | Related citations


Mohler JL et al.
Prostate Cancer. Version 4.2013
NCCN Clinical Practice Guidelines in Oncology 2013 Jul 27.
Abstract | Full text | Related citations


Mohler JL et al.
Prostate Cancer. Version 1.2013
NCCN Clinical Practice Guidelines in Oncology 2012 Dec 4.
Abstract | Full text | Related citations


Mohler JL, Armstrong AJ, Bahnson RR, Boston B, Busby JE, D'Amico AV, Eastham JA, Enke CA, Farrington T, Higano CS, Horwitz EM, Kantoff PW, Kawachi MH, Kuettel M, Lee RJ, MacVicar GR, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Roach M 3rd, Rohren E, Rosenfeld S, Srinivas S, Strope SA, Tward J, Twardowski P, Walsh PC, Ho M, Shead DA.
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.
J Natl Compr Canc Netw. 2012 Sep;10(9):1081-7.
Abstract | Full text | Related citations


Mohler JL et al.
Prostate Cancer. Version 3.2012.
NCCN Clinical Practice Guidelines in Oncology 2012 Apr 12.
Abstract | Full text | Related citations


Mohler JL et al.
Prostate Cancer. Version 4.2011.
NCCN Clinical Practice Guidelines in Oncology 2011 Jun 21.
Abstract | Full text | Related citations


Mohler JL et al.
Prostate Cancer. Version 3.2010.
NCCN Clinical Practice Guidelines in Oncology 2010 Jul 16.
Abstract | Full text | Related citations


Mohler JL et al.
Prostate Cancer. Version 1.2010.
J Natl Compr Canc Netw 8(2):162-200.
Abstract | Full text | Related citations


Mohler JL et al.
Prostate Cancer. Version 1.2010.
NCCN Clinical Practice Guidelines in Oncology 2009 Dec 23.
Abstract | Full text | Related citations


Tools



Cooperberg MR et al.
UCFS-CAPRA Pretreatment risk assessment tool. Qick reference guide.
AbbVie Inc. North Chicago, 2013 Nov.
Abstract | Full text




Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR; Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE).
Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.
Cancer. 2008 Jan 15;112(2):307-14. Epub 2007 Nov 29.
Abstract | Full text | Related citations


Amling CL, Bergstralh EJ, Blute ML, Slezak JM, Zincke H.
Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?
J Urol. 2001 Apr;165(4):1146-51.
Abstract | Related citations


Boccon-Gibod L, Djavan WB, Hammerer P, Hoeltl W, Kattan MW, Prayer-Galetti T, Teillac P, Tunn UW.
Management of prostate-specific antigen relapse in prostate cancer: a European Consensus.
Int J Clin Pract. 2004 Apr;58(4):382-90. Review. Erratum in: Int J Clin Pract. 2004 Jun;58(6):648.
Abstract | Related citations


Gretzer MB, Trock BJ, Han M, Walsh PC.
A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria.
J Urol. 2002 Oct;168(4 Pt 1):1419-22. Erratum in: J Urol 2002 Dec;168(6):2558.
Abstract | Erratum | Related citations


Moul JW.
Prostate specific antigen only progression of prostate cancer.
J Urol. 2000 Jun;163(6):1632-42.
Abstract | Related citations


Ward JF, Blute ML, Slezak J, Bergstralh EJ, Zincke H.
The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy.
J Urol. 2003 Nov;170(5):1872-6.
Abstract | Related citations



Treatment comparison

Localized PCa

Bill-Axelson A, Holmberg L, Ruutu M, Häggman M, Andersson SO, Bratell S, Spångberg A, Busch C, Nordling S, Garmo H, Palmgren J, Adami HO, Norlén BJ, Johansson JE; Scandinavian Prostate Cancer Group Study No. 4.
Radical prostatectomy versus watchful waiting in early prostate cancer.
N Engl J Med. 2005 May 12;352(19):1977-84.
Abstract | Full text | Related citations